Bristol Myers Pink Sheet Forecast - Simple Regression
| BMYMP Stock | USD 850.00 86.80 9.27% |
The Simple Regression forecasted value of Bristol Myers Squibb on the next trading day is expected to be 955.29 with a mean absolute deviation of 23.78 and the sum of the absolute errors of 1,450. Bristol Pink Sheet Forecast is based on your current time horizon.
As of today the relative strength index (rsi) of Bristol Myers' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Bristol Myers hype-based prediction, you can estimate the value of Bristol Myers Squibb from the perspective of Bristol Myers response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Bristol Myers Squibb on the next trading day is expected to be 955.29 with a mean absolute deviation of 23.78 and the sum of the absolute errors of 1,450. Bristol Myers after-hype prediction price | USD 850.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bristol |
Bristol Myers Additional Predictive Modules
Most predictive techniques to examine Bristol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bristol using various technical indicators. When you analyze Bristol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bristol Myers Simple Regression Price Forecast For the 25th of January
Given 90 days horizon, the Simple Regression forecasted value of Bristol Myers Squibb on the next trading day is expected to be 955.29 with a mean absolute deviation of 23.78, mean absolute percentage error of 1,039, and the sum of the absolute errors of 1,450.Please note that although there have been many attempts to predict Bristol Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bristol Myers' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bristol Myers Pink Sheet Forecast Pattern
| Backtest Bristol Myers | Bristol Myers Price Prediction | Buy or Sell Advice |
Bristol Myers Forecasted Value
In the context of forecasting Bristol Myers' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bristol Myers' downside and upside margins for the forecasting period are 953.20 and 957.38, respectively. We have considered Bristol Myers' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Bristol Myers pink sheet data series using in forecasting. Note that when a statistical model is used to represent Bristol Myers pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 125.0566 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 23.7779 |
| MAPE | Mean absolute percentage error | 0.0282 |
| SAE | Sum of the absolute errors | 1450.4499 |
Predictive Modules for Bristol Myers
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bristol Myers Squibb. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bristol Myers After-Hype Price Prediction Density Analysis
As far as predicting the price of Bristol Myers at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bristol Myers or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bristol Myers, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bristol Myers Estimiated After-Hype Price Volatility
In the context of predicting Bristol Myers' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bristol Myers' historical news coverage. Bristol Myers' after-hype downside and upside margins for the prediction period are 847.89 and 852.11, respectively. We have considered Bristol Myers' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bristol Myers is very steady at this time. Analysis and calculation of next after-hype price of Bristol Myers Squibb is based on 3 months time horizon.
Bristol Myers Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bristol Myers is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bristol Myers backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bristol Myers, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 2.09 | 0.00 | 0.07 | 0 Events / Month | 4 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
850.00 | 850.00 | 0.00 |
|
Bristol Myers Hype Timeline
Bristol Myers Squibb is currently traded for 850.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.07. Bristol is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.26%. %. The volatility of related hype on Bristol Myers is about 735.92%, with the expected price after the next announcement by competition of 849.93. The company last dividend was issued on the 1st of December 2022. Assuming the 90 days horizon the next expected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Bristol Myers to cross-verify your projections.Bristol Myers Related Hype Analysis
Having access to credible news sources related to Bristol Myers' direct competition is more important than ever and may enhance your ability to predict Bristol Myers' future price movements. Getting to know how Bristol Myers' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bristol Myers may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RHHVF | Roche Holding AG | (0.04) | 11 per month | 1.44 | 0.11 | 3.94 | (2.76) | 11.81 | |
| RHHBF | Roche Holding AG | (0.04) | 4 per month | 2.56 | 0.05 | 5.57 | (4.32) | 19.30 | |
| RHHBY | Roche Holding Ltd | (1.36) | 9 per month | 0.91 | 0.15 | 3.55 | (1.93) | 12.52 | |
| AZNCF | AstraZeneca PLC | (0.04) | 12 per month | 1.77 | 0.04 | 3.19 | (2.96) | 10.86 | |
| NVSEF | Novartis AG | (1.36) | 15 per month | 2.26 | 0.06 | 5.01 | (5.11) | 14.63 | |
| SNYNF | Sanofi | 0.00 | 0 per month | 0.00 | (0.11) | 2.83 | (3.28) | 8.58 | |
| GLAXF | GSK plc | 0.00 | 0 per month | 2.90 | 0.03 | 6.81 | (6.02) | 16.43 | |
| CHGCY | Chugai Pharmaceutical Co | 0.00 | 0 per month | 1.72 | 0.08 | 3.99 | (2.84) | 11.05 | |
| CHGCF | Chugai Pharmaceutical Co | 0.00 | 0 per month | 3.97 | 0.06 | 7.70 | (6.83) | 18.43 | |
| BAYRY | Bayer AG PK | 0.00 | 0 per month | 1.11 | 0.26 | 6.41 | (2.45) | 15.37 |
Other Forecasting Options for Bristol Myers
For every potential investor in Bristol, whether a beginner or expert, Bristol Myers' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bristol Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bristol. Basic forecasting techniques help filter out the noise by identifying Bristol Myers' price trends.Bristol Myers Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bristol Myers pink sheet to make a market-neutral strategy. Peer analysis of Bristol Myers could also be used in its relative valuation, which is a method of valuing Bristol Myers by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bristol Myers Market Strength Events
Market strength indicators help investors to evaluate how Bristol Myers pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol Myers shares will generate the highest return on investment. By undertsting and applying Bristol Myers pink sheet market strength indicators, traders can identify Bristol Myers Squibb entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 850.0 | |||
| Day Typical Price | 850.0 | |||
| Price Action Indicator | (43.40) | |||
| Period Momentum Indicator | (86.80) |
Bristol Myers Risk Indicators
The analysis of Bristol Myers' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bristol Myers' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bristol pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.07 | |||
| Semi Deviation | 1.53 | |||
| Standard Deviation | 2.08 | |||
| Variance | 4.31 | |||
| Downside Variance | 16.62 | |||
| Semi Variance | 2.34 | |||
| Expected Short fall | (2.40) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bristol Myers
The number of cover stories for Bristol Myers depends on current market conditions and Bristol Myers' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bristol Myers is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bristol Myers' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Bristol Myers Short Properties
Bristol Myers' future price predictability will typically decrease when Bristol Myers' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bristol Myers Squibb often depends not only on the future outlook of the potential Bristol Myers' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bristol Myers' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 B | |
| Cash And Short Term Investments | 17.2 B |
Additional Tools for Bristol Pink Sheet Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.